Literature DB >> 7986900

Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis.

S J van den Hazel1, P Speelman, G N Tytgat, J Dankert, D J van Leeuwen.   

Abstract

Cholangitis is usually the consequence of a combination of factors: impairment of the flow of bile and bacterial colonization of the biliary tract. Although reestablishing biliary drainage is the mainstay of treatment, antibiotics play an important role in the management of cholangitis. In this review, the use of antibiotics for treatment, prophylaxis, and maintenance therapy is discussed. Antibiotics for the treatment of acute cholangitis should be given for 7-10 days in therapeutic dosages and may allow a more selective timing of further interventions. Antibiotic prophylaxis for cholangitis ought to be given as a single (high) dose shortly before surgical or nonsurgical manipulations of the biliary system. Patients with a compromised biliary system (e.g., on account of an endoprosthesis in situ or hepaticojejunostomy) who are prone to develop recurrent bouts of cholangitis may benefit from antibiotic maintenance therapy, given daily in lower-than-therapeutic dosages.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986900     DOI: 10.1093/clinids/19.2.279

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  15 in total

1.  Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography.

Authors:  Thawee Ratanachu-ek; Pitchaya Prajanphanit; Kawin Leelawat; Suchart Chantawibul; Sukij Panpimanmas; Somboon Subwongcharoen; Jerasak Wannaprasert
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

2.  Differences in bile microbiology according to region and hospital: response to correspondence on "Bile microbiology at a hospital in southern Taiwan".

Authors:  W Kwon; S-W Kim; J-Y Jang
Journal:  Infection       Date:  2013-02-10       Impact factor: 3.553

3.  Successful treatment of recurrent cholangitis with antibiotic maintenance therapy.

Authors:  S J van den Hazel; P Speelman; G N Tytgat; D J van Leeuwen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

4.  Effect of internal biliary drainage on plasma levels of endotoxin, cytokines, and C-reactive protein in patients with obstructive jaundice.

Authors:  Francisco J Padillo; Jordi Muntane; Jose L Montero; Javier Briceño; Gonzalo Miño; Guillermo Solorzano; Antonio Sitges-Serra; Carlos Pera-Madrazo
Journal:  World J Surg       Date:  2002-09-26       Impact factor: 3.352

5.  Fever-based antibiotic therapy for acute cholangitis following successful endoscopic biliary drainage.

Authors:  Hirofumi Kogure; Takeshi Tsujino; Keisuke Yamamoto; Suguru Mizuno; Yoko Yashima; Hiroshi Yagioka; Kazumichi Kawakubo; Takashi Sasaki; Yousuke Nakai; Kenji Hirano; Naoki Sasahira; Hiroyuki Isayama; Minoru Tada; Takao Kawabe; Masao Omata; Sohei Harada; Yasuo Ota; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2011-08-13       Impact factor: 7.527

Review 6.  Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis.

Authors:  Fu Yu Li; Nan Sheng Cheng; Hui Mao; Li Sheng Jiang; Jing Qiu Cheng; Quan Sheng Li; Sanjay Munireddy
Journal:  World J Surg       Date:  2009-10       Impact factor: 3.352

7.  In vitro activity of moxifloxacin and piperacillin/sulbactam against pathogens of acute cholangitis.

Authors:  Andreas Weber; Wolfgang Huber; Klaus Kamereck; Philipp Winkle; Petra Voland; Hans Weidenbach; Roland M Schmid; Christian Prinz
Journal:  World J Gastroenterol       Date:  2008-05-28       Impact factor: 5.742

8.  Recurrent Pyogenic Cholangitis.

Authors:  D. Rohan Jeyarajah
Journal:  Curr Treat Options Gastroenterol       Date:  2004-04

9.  Early oral antibiotic switch compared with conventional intravenous antibiotic therapy for acute cholangitis with bacteremia.

Authors:  Tae Young Park; Jung Sik Choi; Tae Jun Song; Jae Hyuk Do; Seong-Ho Choi; Hyoung-Chul Oh
Journal:  Dig Dis Sci       Date:  2014-06-05       Impact factor: 3.199

10.  Changing trend in bile microbiology and antibiotic susceptibilities: over 12 years of experience.

Authors:  W Kwon; J-Y Jang; E-C Kim; J W Park; I W Han; M J Kang; S-W Kim
Journal:  Infection       Date:  2012-11-21       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.